Company page

Precigen, Inc.

Precigen, Inc. is a public company traded under the ticker PGEN in the American market. With a market capitalization of approximately $1.59 billion, Precigen focuses on advancing innovative therapies in the field of biotechnology. The company is dedicated to developing transformative treatments aimed at addressing unmet medical needs.